Loading
Virologist who mapped how Epstein-Barr virus drives nasopharyngeal cancer and is developing vaccines against it.
Mu-Sheng Zeng is Professor and Director of the State Key Laboratory of Oncology in South China at Sun Yat-sen University Cancer Center in Guangzhou. A virologist, he mapped how Epstein-Barr virus drives nasopharyngeal carcinoma, and his group identified high-risk EBV subtypes linked to the disease and studies how the virus enters cells. His publications include a genome sequencing analysis identifying Epstein-Barr virus subtypes associated with a high risk of nasopharyngeal carcinoma. He is now developing prophylactic vaccine candidates against EBV, with interests in viral oncology and nasopharyngeal carcinoma biology.
| Title | Journal | Year |
|---|---|---|
| Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma | Nature Genetics | 2019 |
Shares Sun Yat-sen University Cancer Center, Head and neck squamous cell carcinoma.
Shares Sun Yat-sen University Cancer Center, Head and neck squamous cell carcinoma.
Shares HPV & HBV vaccination, Head and neck squamous cell carcinoma.
Shares HPV & HBV vaccination, Head and neck squamous cell carcinoma.
Shares Sun Yat-sen University Cancer Center, Head and neck squamous cell carcinoma.
Shares Sun Yat-sen University Cancer Center, Head and neck squamous cell carcinoma.
Shares HPV & HBV vaccination, Head and neck squamous cell carcinoma.
Shares HPV & HBV vaccination, Head and neck squamous cell carcinoma.